EMA recommends Moderna COVID-19 vaccine for authorisation in the EU

EMA

6 January 2021 - EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine Moderna to prevent coronavirus disease in people from 18 years of age. 

This is the second COVID-19 vaccine that EMA has recommended for authorisation.

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Europe , Vaccine , COVID-19